Clinical Trial Results:
Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1
Summary
|
|
EudraCT number |
2011-004394-90 |
Trial protocol |
AT |
Global completion date |
17 Oct 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Jun 2021
|
First version publication date |
03 Jun 2021
|
Other versions |
|
Summary report(s) |
Spindelboeck et al. Keyhole-limpet-hemocyanin induces myeloid dendritic cells in chronic hepatitis C and compensated cirrhosis – results from a pilot study (unpublished manuscript, June 2015) |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.